Nanox Imaging Ltd. (NASDAQ: NNOX), a leader in innovative medical imaging technology, announced that its subsidiary, Nanox AI Ltd., has entered into a sales reseller agreement with Vertec Scientific Ltd. for the commercialization of its Nanox.AI bone solution, HealthOST, in the United Kingdom. The agreement grants Vertec an exclusive license to market and resell HealthOST in the UK, subject to minimum annual license commitments, for an initial three-year term.
HealthOST is an FDA-cleared and UKCA/CE-marked AI software solution that analyzes eligible routine CT scans to support clinicians in evaluating and assessing musculoskeletal disease of the spine, including osteoporosis. This technology is designed to leverage existing CT scans—often performed for unrelated reasons—to opportunistically detect vertebral fragility fractures and other signs of bone disease, potentially enabling earlier intervention and improved patient outcomes.
The significance of this partnership is underscored by a recent recommendation from the National Institute for Health and Care Excellence (NICE). In November 2025, NICE recommended HealthOST and a previous version, HealthVCF, among five AI technologies for National Health Service (NHS) use as options to aid opportunistic detection of vertebral fragility fractures. This endorsement positions HealthOST as a valuable tool within the UK's public healthcare system, potentially reducing the burden of osteoporosis-related fractures, which are a major cause of morbidity and healthcare costs.
By partnering with Vertec Scientific, a well-established supplier of medical equipment in the UK, Nanox aims to accelerate the adoption of HealthOST across NHS trusts and private healthcare providers. The exclusive agreement ensures that Vertec will focus on marketing and selling the solution, with minimum annual commitments that reflect the expected demand. This move aligns with Nanox's broader strategy to expand the reach of medical imaging beyond traditional hospital settings and to support preventive healthcare initiatives.
Osteoporosis is a silent disease that often goes undiagnosed until a fracture occurs. Opportunistic screening using routine CT scans offers a cost-effective way to identify at-risk patients without additional radiation exposure or patient visits. The NICE recommendation and the new reseller agreement could significantly increase the detection rate of vertebral fractures and osteoporosis in the UK, leading to earlier treatment and potentially reducing the incidence of hip and other fractures, which are associated with high morbidity and mortality in the elderly.
For the healthcare industry, this development highlights the growing role of AI in diagnostic imaging. AI solutions like HealthOST can augment radiologists' capabilities by flagging incidental findings that might otherwise be overlooked, thereby improving diagnostic accuracy and efficiency. The integration of AI into routine workflows is expected to become more prevalent, driven by clinical evidence and health technology assessments like those conducted by NICE.
Nanox's ecosystem includes the Nanox.ARC imaging system, Nanox.AI suite, Nanox.CLOUD, and other digital health solutions. The company's focus on preventive health and early detection is exemplified by this AI-driven bone health solution. The UK market represents a significant opportunity, especially with the NHS's commitment to innovation and improving patient outcomes.
This agreement also demonstrates a viable commercial pathway for AI medical technologies, combining regulatory approvals, clinical recommendations, and strategic distribution partnerships. As AI continues to transform healthcare, collaborations like this one will be crucial in bringing these technologies to patients and clinicians effectively.
The news of this partnership comes as part of Nanox's ongoing efforts to globalize its offerings. With the UK being a key healthcare market, the exclusive agreement with Vertec Scientific could serve as a model for future expansions into other regions.
For more information about Nanox and its solutions, visit the company's newsroom at http://ibn.fm/NNOX.
